You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-JAK-Peficitinib
Peficitinib

Chemical Structure : Peficitinib

CAS No.: 944118-01-8

Peficitinib (ASP015K, JNJ-54781532)

Catalog No.: PC-45652Not For Human Use, Lab Use Only.

Peficitinib (ASP015K, JNJ-54781532) is a potent JAK inhibitor with IC50s of 3.9 and 0.7 nM for JAK1 and JAK3 respectively.

Packing Price Stock Quantity
10 mg $98 In stock
25 mg $158 In stock
50 mg $248 In stock
100 mg $398 In stock
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Peficitinib (ASP015K, JNJ-54781532) is a potent JAK inhibitor with IC50s of 3.9 and 0.7 nM for JAK1 and JAK3 respectively.
Peficitinib inhibits IL-2-dependent T cell proliferation in vitro and STAT5 phosphorylation in vitro and ex vivo.
Peficitinib dose-dependently suppresses bone destruction and paw swelling in an adjuvant-induced arthritis model in rats; orally bioactive.

Physicochemical Properties

M.Wt 326.3929
Formula C18H22N4O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 60 mg/mL

Chemical Name/SMILES

1H-Pyrrolo[2,3-b]pyridine-5-carboxamide, 4-[(5-hydroxytricyclo[3.3.1.13,7]dec-2-yl)amino]-, stereoisomer

References

1. Oda K, et al. Xenobiotica. 2015;45(6):488-94.

2. Takeuchi T, et al. Ann Rheum Dis. 2016 Jun;75(6):1057-64.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: